Gross Profit Summary of Telescope Innovations Corp.

Telescope Innovations Corp.'s latest annual gross profit in 2022 was 595.39 Thousand CAD , down 0.0% from previous year.
Telescope Innovations Corp.'s latest quarterly gross profit in 2023 Q3 was 1.01 Million CAD , up 24.09% from previous quarter.
Telescope Innovations Corp. reported a annual gross profit of - CAD in annual gross profit 2021, down 0.0% from previous year.
Telescope Innovations Corp. reported a annual gross profit of - CAD in annual gross profit 2020, down 0.0% from previous year.
Telescope Innovations Corp. reported a quarterly gross profit of 816.32 Thousand CAD for 2023 Q2, up 59.73% from previous quarter.
Telescope Innovations Corp. reported a quarterly gross profit of 511.06 Thousand CAD for 2023 Q1, down -14.16% from previous quarter.

Annual Gross Profit Chart of Telescope Innovations Corp. (2022 - 2020)

Name	Gross Profit	Gross Profit Difference
Algernon Pharmaceuticals Inc.	-50.39 Thousand CAD	1281.392%
Asep Medical Holdings Inc	-113.74 Thousand CAD	623.473%
BetterLife Pharma Inc.	- CAD	-Infinity%
BioVaxys Technology Corp.	- CAD	-Infinity%
ChitogenX Inc.	-42 Thousand CAD	1517.614%
Rapid Dose Therapeutics Corp.	563.4 Thousand CAD	-5.678%
Defence Therapeutics Inc.	-90.92 Thousand CAD	754.83%
Entheon Biomedical Corp.	250.32 Thousand CAD	-137.852%
Gemina Laboratories Ltd.	-93.36 Thousand CAD	737.69%
Glow Lifetech Corp.	-505.62 Thousand CAD	217.755%
Lexston Life Sciences Corp.	-26.39 Thousand CAD	2355.808%
Pharmala Biotech Holdings Inc.	454.09 Thousand CAD	-31.116%
Doseology Sciences Inc.	-36.08 Thousand CAD	1750.033%
MYND Life Sciences Inc.	-332.99 Thousand CAD	278.804%
Nova Mentis Life Science Corp.	25.4 Thousand CAD	-2243.625%
PharmaTher Holdings Ltd.	-711.00 CAD	83840.928%
PreveCeutical Medical Inc.	-9856.00 CAD	6140.97%